As a veteran who was wounded during a mortar attack in Iraq, I’m all too familiar with the fact that our enemies can hit us ...

That’s why I’m increasingly concerned that America is unprepared for one of the most critical battles of the 21st century — ...

Takeda Pharmaceuticals is cutting more than 200 jobs across its U.S. workforce as it prepares for an upcoming loss of ...

A fierce dispute between an American venture capital firm and the family investment office of a Russian billionaire has ...

Industry leaders came away from the J.P. Morgan Healthcare Conference feeling optimism for the industry that they say is ...

Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...

Despite an unusual lack of major announcements, energy is high. And a few key themes dominate discussions.

From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA. Dr. Ge Michael, President and CEO of Sichuan Kelun-Biotech Biopharmaceutical ...

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

Investors are eyeing a rebound in the U.S. biotech sector in 2026, as more companies ​are expected to go public amid a ...

The new year has ushered in a flow of biotech-specific funds, including $700 million from Andreessen Horowitz (A16z). | The ...

Andreessen Horowitz has raised more than $15 billion — its biggest ever funding haul — with plans to invest in industries ...